Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | Award | $5M | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | ExerciseD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | Exercise | — | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | Other | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | Award | $6.3M | SEC | |
Oruka Therapeutics, Inc.Listing on record | AwardD (derivative) | $3.7M | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | — | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | Other | — | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | Other | — | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | Buy | $394.5K | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | Buy | $396K | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | AwardD (derivative) | — | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | Buy | $161.5K | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | Buy | $110.2K | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | — | SEC | |
MedGen, Inc.Listing unverified | AwardD (derivative) | — | SEC |